After the New Year: A Caregiver’s Roadmap to HER2‑Mutant Lung Cancer Care in China
A firsthand guide to navigating late-stage lung cancer care in China: cross‑province insurance filings, Shenzhen vs. Guangzhou hospital choices, HER2 Exon20ins treatment access (chemo before T‑DXd in this case), clinical trials, 门诊慢特病 setup, and the exact questions to ask your oncologist.